格隆匯公吿精選︱安琪酵母:擬實施無血清細胞培養基核心技術攻關工程項目;哈焊華通:產品可以用於可控核聚變項目

【熱點追蹤】
萊紳通靈(603900.SH):公司股票短期內升幅和換手率較大,後續股票可能存在較大下跌風險
榮晟環保(603165.SH):控股股東、實際控制人馮榮華被採取強制措施
哈焊華通(301137.SZ):產品可以用於可控核聚變項目
【項目投資】
安琪酵母(600298.SH):擬實施無血清細胞培養基核心技術攻關工程項目
金丹科技(300829.SZ):擬投資1.63億元建設供水中心項目
正裕工業(603089.SH):蕪湖榮基公司擬在泰國設立新的生產基地
【中標合同】
平治信息(300571.SZ):簽訂陝西電信GPU算力建設項目合同
江西長運(600561.SH):子公司擬簽署不動產租賃合同
復潔環保(688335.SH):簽訂2.44億元《白龍港污水處理廠擴建三期工程BLG3-2.3標污泥幹化造粒系統、除臭系統及其配套設備採購及伴隨服務合同》
【H股上市】
紫金礦業(601899.SH):擬將控股子公司紫金黃金國際分拆至香港聯交所主板上市
國恩股份(002768.SZ):擬發行H股股票並申請在香港聯交所上市
【股權收購】
廣聯航空(300900.SZ):擬收購天津躍峯51%股份實現對其控股
東宏股份(603856.SH):擬將管道集團7.296%股權全部轉讓給水務集團
羅普斯金(002333.SZ):擬出售豐鑫園90%股權、湖北公司80%股權
【回購】
海興電力(603556.SH):擬回購1億元-2億元公司股份
【增減持】
惠柏新材(301555.SZ):股東東瑞國際有限公司擬合計減持不超3.00%股份
萬里揚(002434.SZ):華潤信託·華穎16號擬減持不超3%股份
美聯新材(300586.SZ):張盛業擬減持不超過3%股份
新華醫療(600587.SH):山東健康集團擬增持1億元-2億元股份
【其他】
譽衡藥業(002437.SZ):與興和製藥就佩瑪貝特片簽訂共同推廣協議
*ST奧維(002231.SZ):公司股票交易被疊加實施其他風險警示
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.